>NEWS
NEWS2019-04-16T20:08:19+00:00

SWIFT NEWS

Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation

August 3rd, 2017|

Swift Biosciences Launches Next Phase of Company Growth and Expansion

Company completes Series D funding and adds two new directors to board. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the company for accelerated growth. The Series D round was led by Arboretum Ventures

June 29th, 2017|

Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene

Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting – Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)

March 22nd, 2017|

Swift Biosciences Expands Team, Hires Vice President of Marketing

Ann Arbor, MI, February 8, 2017 – Swift Biosciences, today announced that it has hired Candia Brown as Vice President of Global Marketing. Brown brings over 25 years of biotechnology experience including product development, product management and market development. “Candia‘s deep expertise in the genomic [...]

February 8th, 2017|